Safety and tolerability study of Cotadutide in Japanese obese subjects with type 2 diabetes melitus

Trial Identifier: D5671C00003
Sponsor: AstraZeneca
NCTID:: NCT04208620
Start Date: January 2020
Primary Completion Date: July 2020
Study Completion Date: July 2020
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
Japan Shinjuku-ku, Japan, 162-0053
Japan Shinjuku-ku, Japan, 160-0008
Japan Suita-shi, Japan, 565-0853